S. Matsuura

发表

Effects of Primer-Template Sequence on ATP-dependent Removal of Chain-terminating Nucleotide Analogues by HIV-1 Reverse Transcriptase*

W. Scott, P. R. Meyer, A. Smith, 2004, Journal of Biological Chemistry.

Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.

A. So, W. Scott, P. R. Meyer, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Chain-Terminating Dinucleoside Tetraphosphates Are Substrates for DNA Polymerization by Human Immunodeficiency Virus Type 1 Reverse Transcriptase with Increased Activity against Thymidine Analogue-Resistant Mutants

W. Scott, P. R. Meyer, A. Smith, 2006, Antimicrobial Agents and Chemotherapy.

Effects of Speciﬁc Zidovudine Resistance Mutations and Substrate Structure on Nucleotide-Dependent Primer Unblocking by Human Immunodeﬁciency Virus Type 1 Reverse Transcriptase

J. Mellors, A. So, W. Scott, 2002 .

Nucleotide-induced stable complex formation by HIV-1 reverse transcriptase.

S. Sharma, A. So, W. Scott, 1997, Biochemistry.

Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet.

W. Rutvisuttinunt, A. So, W. Scott, 2007, Journal of molecular biology.

Epitopes on the major capsid protein of simian virus 40.

K. Brew, L. Babe, W. Scott, 1989, The Journal of biological chemistry.

Relationship between 3′-Azido-3′-Deoxythymidine Resistance and Primer Unblocking Activity in Foscarnet-Resistant Mutants of Human Immunodeficiency Virus Type 1 Reverse Transcriptase

J. Mellors, W. Scott, Holly Z. Bazmi, 2003, Journal of Virology.

Effects of Dipeptide Insertions between Codons 69 and 70 of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Primer Unblocking, Deoxynucleoside Triphosphate Inhibition, and DNA Chain Elongation

B. Larder, J. Lennerstrand, W. Scott, 2003, Journal of Virology.

A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase.

A. Mian, A. So, W. Scott, 1999, Molecular cell.

Differential Removal of Thymidine Nucleotide Analogues from Blocked DNA Chains by Human Immunodeficiency Virus Reverse Transcriptase in the Presence of Physiological Concentrations of 2′-Deoxynucleoside Triphosphates

R. Schinazi, A. So, W. Scott, 2000, Antimicrobial Agents and Chemotherapy.

Effects of Specific Zidovudine Resistance Mutations and Substrate Structure on Nucleotide-Dependent Primer Unblocking by Human Immunodeficiency Virus Type 1 Reverse Transcriptase

J. Mellors, A. So, W. Scott, 2002, Antimicrobial Agents and Chemotherapy.

A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation

Antonio J. Acosta-Hoyos, W. Scott, P. R. Meyer, 2012, Journal of Virology.

HIV-1 Infection Is Blocked at an Early Stage in Cells Devoid of Mitochondrial DNA

A. Barrientos, W. Scott, S. Matsuura, 2013, PloS one.

Reverse transcriptase mutations in HIV-1-infected children treated with zidovudine.

M. Brown, A. Unal, W. Scott, 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

A Role of Template Cleavage in Reduced Excision of Chain-Terminating Nucleotides by Human Immunodeficiency Virus Type 1 Reverse Transcriptase Containing the M184V Mutation

Antonio J. Acosta-Hoyos, W. Scott, S. Matsuura, 2012, Journal of Virology.